@j0nhyde @_eleven13_ They have just reported on a new clinical trial, they used a tapering schedule of 2 months which really is not the best for many patients and so they found that many did not do well but they have reported this as "relapse". https://t.c
@DeeMangin @tony_kendrick @GlynLewis9 @GemmaLewis13 may we have a word about the tapering plan in #ANTLER https://t.co/NqxDsk1YS1 A taper of two months?? Reductions by 50%?? "In the second month they will take half the dose and placebo on alternate days...
Trial alert: this antidepressant discontinuation study will assess withdrawal symptoms, but not as primary outcome. High risk that it adds to the long-term studies which are much biases due to withdrawal effects that are conflated with relapses. https://t
Open Access UCL Research: A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants https://t.co/8nlQXYkpIT